Cargando…
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases
The pleiotropic hormone relaxin-2 plays a pivotal role in the physiology and pathology of the cardiovascular system. Relaxin-2 exerts relevant regulatory functions in cardiovascular tissues through the specific receptor relaxin family peptide receptor 1 (RXFP1) in the regulation of cardiac metabolis...
Autores principales: | Aragón-Herrera, Alana, Feijóo-Bandín, Sandra, Anido-Varela, Laura, Moraña-Fernández, Sandra, Roselló-Lletí, Esther, Portolés, Manuel, Tarazón, Estefanía, Gualillo, Oreste, González-Juanatey, José Ramón, Lago, Francisca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317583/ https://www.ncbi.nlm.nih.gov/pubmed/35887517 http://dx.doi.org/10.3390/jpm12071021 |
Ejemplares similares
-
Adipokines and Inflammation: Focus on Cardiovascular Diseases
por: Feijóo-Bandín, Sandra, et al.
Publicado: (2020) -
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models
por: Feijóo-Bandín, Sandra, et al.
Publicado: (2022) -
Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers
por: Aragón-Herrera, Alana, et al.
Publicado: (2022) -
Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives
por: Feijóo-Bandín, Sandra, et al.
Publicado: (2017) -
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
por: Aragón-Herrera, Alana, et al.
Publicado: (2022)